Amoéba S.A. (ALMIB.PA)
Amoéba S.A. operates in the Agricultural Inputs industry of the Basic Materials sector, headquartered in Chassieu, AR, FR. The stock last traded at $0.69, down 1.01% on the session, giving a market capitalisation of $53.4M. Its beta of 0.24 implies it has historically moved less than the broad market.
Amoéba S.A. focuses on the development and commercialization of anti-microbial and anti-fungal products. The company's primary innovation centers on harnessing the unique properties of the Willaertia magna C2c Maky amoeba, which it is applying across various fields. These applications are designed to mitigate biological risks in critical areas like water purification, the treatment of human injuries, and safeguarding agricultural crops. Established in 2010, Amoéba S.A. is based in Chassieu, France.
Amoéba S.A. is most often compared with the following Basic Materials names: